Stock listing
Heartbeam, Inc.
Selected listing: BEAT · NASDAQ · USD · US
Heartbeam, Inc. (NASDAQ:BEAT), Health Technology. Latest release Oct 5, 2026: HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
- Ticker
- NASDAQ:BEAT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
About Heartbeam, Inc.
Heartbeam, Inc. is a public company traded under the ticker BEAT on the American market. Heartbeam focuses on innovative solutions in the healthcare sector, particularly in cardiac care technology.
Latest news from Heartbeam, Inc.
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
October 4, 2026
HeartBeam, Inc. Letter to Shareholders
September 21, 2026
HeartBeam Reports Second Quarter 2026 Results
August 13, 2026
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
July 29, 2026
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
July 13, 2026